Login / Signup

Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients.

Maode BaoRun ShiKai ZhangYanbo ZhaoYanfang WangXuanwen Bao
Published in: The EPMA journal (2019)
Our study might contribute to the optimization of risk stratification for survival and personalized management of ccRCC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported